Variable | Study group N = 78, n (%) | Placebo group N = 84, n (%) | RR (95%CI) | P-value |
---|---|---|---|---|
Blood loss > 500 (ml) | 4(5.13%) | 6(7.14%) | 0.71(0.38–1.79) | 0.5956 |
Additional interventions | ||||
Blood transfusion | 1(1.28%) | 3(3.57%) | 0.25(0.09–2.82) | 0.3496 |
Uterotonics | 3(3.85%) | 14(16.67%) | 0.24(0.12–0.96) | 0.007 |
Patients with side effects | ||||
Minor side effects: Diarrhoea | 1(1.15%) | 0(0%) |